Stay updated with breaking news from Icahn Mount. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New York, NY (PRWEB) December 21, 2022 -- New York, NY (December 21, 2022) – Using machine learning and clinical data from electronic health records,
Diagnosing early-stage lung cancer with low-dose computed tomography (CT) screening drastically improves the survival rate of cancer patients over a 20-year period, according to a large-scale international study being presented by Mount Sinai researchers at the annual meeting of the Radiological Society of North America.
A gene recognized as the strongest risk factor for Alzheimer's disease (AD) alters the way cholesterol moves around the brain and as we age, this altered movement likely contributes to loss of learning and memory, a team of researchers from the Icahn School of Medicine at Mount Sinai and the Massachusetts Institute of Technology reports.
The problem is only barely starting to get the attention of employers, the health care system, and policymakers.
Newest grant brings total to $2 million for studies that could result in new therapeutic approaches